Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, +46

Clinical Microbiology and Infection

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

Sixten Körper, Daniel Zickler, Thomas Wiesmann, +23

Journal of Clinical Investigation

Clinical ManagementImmunohematologyControl GroupLong CovidImmunodeficiencies +12

Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial

Achim J. Kaasch, Luis Eduardo López-Cortés, Jesús Rodríguez‐Baño, +63

The Lancet Infectious Diseases

Early Oral SwitchHealthcare-associated InfectionPatient SafetyHospital EpidemiologyNon-inferiority Trial +4

Overt Increase of Oxidative Stress and DNA Damage in Murine and Human Colitis and Colitis-Associated Neoplasia

Adrian Frick, Vineeta Khare, Gregor Paul, +6

Molecular Cancer Research

IL10R2 Overexpression Promotes IL22/STAT3 Signaling in Colorectal Carcinogenesis

Vineeta Khare, Gregor Paul, Oliver Movadat, +6

Cancer Immunology Research

Improving Emergency Department Patient-Physician Conversation Through an Artificial Intelligence Symptom-Taking Tool: Mixed Methods Pilot Observational Study

Justus Scheder-Bieschin, Bibiana Blümke, Erwin de Buijzer, +10

JMIR Formative Research

One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients

Sixten Körper, Beate Grüner, Daniel Zickler, +36

Journal of Clinical Investigation

Severe Covid-19 PatientsCovid-19 EpidemiologyCcp GroupCovid-19Clinical Epidemiology +14

The humoral immune response more than one year after SARS-CoV-2 infection: low detection rate of anti-nucleocapsid antibodies via Euroimmun ELISA

Gregor Paul, Philipp Strnad, Oliver Wienand, +8

Infection

High Dose Convalescent Plasma in COVID-19: Results from the Randomized Trial CAPSID

Sixten Körper, Daniel Zickler, Thomas Wiesmann, +23

Conclusion CcpLong CovidImmunodeficienciesCovid-19 PandemicClinical Epidemiology +10

Surgical Procedure Time and Mortality in Patients with Infective Endocarditis Caused by Staphylococcus aureus or Streptococcus Species

Gregor Paul, Laurin Ochs, Christopher Hohmann, +8

Journal of Clinical Medicine